Quality and regulation are major concernscompounded drugs are not FDA-approved
This also shifted GLP-1 therapy from being purely a metabolic medication to a cardiovascular diseasemodifying therapy, even in patients without diabetes
If you are taking Sublingual Semaglutide for the first time, you will be instructed to begin with a titration as directed by your provider
Although this initial case only involves the drug manufacturers as defendants, it is anticipated that more claims and lawsuits targeting not only Ozempic, but also other GLP-1 drugs, will emerge
Market launch: Manufacturing scale-up, distribution, and pharmacy availability
Retrieved June 11, 2025, from Swiss Medica